A large French clinical trial found that patients with moderate to severe ARDS who received sevoflurane had fewer ventilator-free days and lower 90-day survival than those sedated with propofol.
A 5-year national study of over 8,800 cases found that fewer than 40% of patients with gonorrhea and just 14% of those with chlamydia were treated with CDC-recommended antibiotics in U.S. primary care.